Australian Government To Fund Cervical Cancer Vaccine Gardasil

Featured Article
Main Category: Sexual Health / STDs
Also Included In: Women's Health / Gynecology;  Pediatrics / Children's Health;  Immune System / Vaccines
Article Date: 29 Nov 2006 - 11:00 PST

email to a friend   printer friendly   view / write opinions   rate article

As from the beginning of 2007 the Commonwealth Government (Australia) will pay for the cervical cancer vaccine, Gardasil, for females aged 12-26. The vaccine will be on the National Immunisation Program on an ongoing basis for 12-13 year-old girls - to be given at school. A two-year catch-up program will also be publicly funded for 13-18 year-old girls (at school). Women aged 18-26 will be vaccinated, free-of-charge, by their GPs.

The Australian government estimates the whole cost will be about $436 (Australian dollars) for the 2006-2007 and 2009-2010 programs.

The vaccine makers, CSL, initially submitted the vaccine for approval to the PBAC (Pharmaceutical Benefits Advisory Committee) in November 2005. The PBAC turned down public funding as there were concerns about the program's cost-effectiveness. Tony Abbott, Health Minister, asked the PBAC to consider a revised submission, which included an immunisation program through schools. The PBAC agreed to have another look. CSL accepted a lower price for Gardasil, and committed to a substantial booster program (if necessary) over the next two decades. The PBAC finally decided that a publicly funded Gardasil program was cost-effective.

Tony Abbott says the accelerated timeframe for consideration did not compromise the quality of the decision-making process.

Fact sheet about the Human Papilloma Virus (HPV) vaccines (Australian Government, Dept of Health and Ageing)

Written by: Christian Nordqvist
Editor: Medical News Today


Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today